Evigrade

Low testosterone in men (supplement marketing)

A middle-aged-man complaint of low libido, morning fatigue and lost muscle mass, popularly blamed on «low testosterone». Real hypogonadism requires two morning total testosterone measurements below 12 nmol/L plus symptoms and confirmed cause (Endocrine Society 2018, ISSAM 2022). Supplements – boron, zinc, tribulus, ashwagandha, tongkat ali – are marketed as testosterone boosters, yet large meta-analyses and systematic reviews show no clinically meaningful testosterone rise in men without confirmed hypogonadism.

ICD-10 E29.17 drugs

Also known as: Low T, Andropause, Testosterone boosters

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

How to read tiers A–F

Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.

  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit